ArticleNPJ precision oncology2024

Rapid response to selpercatinib in RET fusion positive pancreatic neuroendocrine carcinoma confirmed by smartwatch.

Barbara Deschler-Baier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.